ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines

In Vivo

Volumn 25, Issue 1, 2011, Pages 69-76

  Yu, Chunyan ^a,b   Yao, Zhi ^b   Dai, Jinlu ^a   Zhang, Honglai ^a   Escara Wilke, June ^a   Zhang, Xiaohua ^a   Keller, Evan T ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

ALDH; CD44; Prostate cancer; Stem cell

Indexed keywords

ALDEHYDE DEHYDROGENASE; HERMES ANTIGEN; MATRIGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CULTURE; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CELL POPULATION; CELL PROLIFERATION; CELL STRAIN LNCAP; CLONOGENIC ASSAY; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LATENT PERIOD; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR CELL;

EID: 79952035236     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56(2): 106-130, 2006.
2. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414(6859): 105-111, 2001.
3. Huntly BJ and Gilliland DG: Leukaemia stem cells and the evolution of cancer stem cell research. Nat Rev Cancer 5(4): 311-321, 2005. (Pubitemid 40488636)
4. Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, Schneider-Broussard R and Jeter C: Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol Carcinog 46(1): 1-14, 2007. (Pubitemid 46095228)
5. De Marzo AM, Nelson WG, Meeker AK and Coffey DS: Stem cell features of benign and malignant prostate epithelial cells. J Urol 160(6 Pt 2): 2381-2392, 1998.
6. Ponta H, Sherman L and Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4(1): 33-45, 2003. (Pubitemid 36077255)
7. Draffin JE, McFarlane S, Hill A, Johnston PG and Waugh DJ: CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 64(16): 5702-5711, 2004. (Pubitemid 39095568)
8. + stem/progenitor cells to bone marrow. Blood 103(8): 2981-2989, 2004. (Pubitemid 38451670)
9. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M and Werner C: Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22(3): 377-384, 2004. (Pubitemid 38736621)
10. Schwartz PH, Bryant PJ, Fuja TJ, Su H, O'Dowd DK and Klassen H: Isolation and characterization of neural progenitor cells from post-mortem human cortex. J Neurosci Res 74(6): 838-851, 2003. (Pubitemid 37490416)
11. Liu Y, Han SS, Wu Y, Tuohy TM, Xue H, Cai J, Back SA, Sherman LS, Fischer I and Rao MS: CD44 expression identifies astrocyte-restricted precursor cells. Dev Biol 276(1): 31-46, 2004.
12. Gudjonsson T, Villadsen R, Nielsen HL, Ronnov-Jessen L, Bissell MJ and Petersen OW: Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 16(6): 693-706, 2002. (Pubitemid 34274039)
13. + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25(12): 1696-1708, 2006.
14. Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65(23): 10946-10951, 2005. (Pubitemid 41713363)
15. Kondo T, Setoguchi T and Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 101(3): 781-786, 2004. (Pubitemid 38121035)
16. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101(39): 14228-14233, 2004.
17. Zhou L, Wei X, Cheng L, Tian J and Jiang JJ: CD133, one of the markers of cancer stem cells in Hep-2 cell line. Laryngoscope 117(3): 455-460, 2007. (Pubitemid 46407753)
18. + hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Comm 351(4): 820-824, 2006. (Pubitemid 44715858)
19. Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH and Nolta JA: Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104(6): 1648-1655, 2004. (Pubitemid 39202270)
20. Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, Eades WC, Creer MH and Nolta JA: Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 107(5): 2162-2169, 2006. (Pubitemid 43289402)
21. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3): 313-323, 2007. (Pubitemid 47355323)
22. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17(10): 1253-1270, 2003.
23. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18): 5821-5828, 2003. (Pubitemid 37187480)
24. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65(13): 5506-5511, 2005.
25. Abilez O, Benharash P, Mehrotra M, Miyamoto E, Gale A, Picquet J, Xu C and Zarins C: A novel culture system shows that stem cells can be grown in 3D and under physiologic pulsatile conditions for tissue engineering of vascular grafts. J Surg Res 132(2): 170-178, 2006.
26. Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S and Rhim JS: Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 67(7): 3153-3161, 2007. (Pubitemid 46724852)
27. Lioznov MV, Freiberger P, Kroger N, Zander AR and Fehse B: Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants. Bone Marrow Transplant 35(9): 909-914, 2005. (Pubitemid 40667634)
28. Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ and McDonnell DP: Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 103(31): 11707-11712, 2006. (Pubitemid 44182515)
29. Al-Hajj M and Clarke MF: Self-renewal and solid tumor stem cells. Oncogene 23(43): 7274-7282, 2004. (Pubitemid 39382161)
30. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature 432(7015): 396-401, 2004. (Pubitemid 39551674)
31. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT and Jacks T: Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6): 823-835, 2005. (Pubitemid 40806415)
32. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE and Herlyn M: A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65(20): 9328-9337, 2005. (Pubitemid 41508000)
33. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, Strazzer S, Bresolin N and Comi GP: Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 24(4): 975-985, 2006. (Pubitemid 44464730)
34. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS and Dontu G: ALDHl is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5): 555-567, 2007. (Pubitemid 350056407)
35. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C and Clarke MF: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104(24): 10158-10163, 2007. (Pubitemid 47175279)
36. - cancer cells are similarly tumorigenic. Cancer Res 65(14): 6207-6219, 2005. (Pubitemid 40994406)
37. Miki J and Rhim JS: Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells. Prostate Cancer Prostatic dis 11(1): 32-39, 2008.
38. Harper LJ, Piper K, Common J, Fortune F and Mackenzie IC: Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J Oral Pathol Med 36(10): 594-603, 2007. (Pubitemid 47609813)